Polycystic ovarian disease (PCOD): an Ayurvedic approach

AYURLINE: IJ-RIM


International Journal of Research in Indian Medicine

PDF

Keywords

Polycystic ovarian disease , PCOD, infertility, Rajovikruti

How to Cite

Jere, N., Avalaskar, A., & Kore, sharayu. (2017). Polycystic ovarian disease (PCOD): an Ayurvedic approach. Ayurline: International Journal of Research in Indian Medicine, 1(02). https://doi.org/10.52482/ayurline.v1i02.59

Abstract

Polycystic ovarian disease, PCOD is the most common clinical condition, we all encounter in our practise. Few years back we used to see it in infertile women but now it presents itself as early as in adolescents as well. Now-a-days numbers of cases about menstrual complaints in female are rising in a very vast manner. So many factors playan important role in such kind of problem including food, lifestyle, stress etc. this leads to physical as well as emotional disturbances of the patient. Also it can lead to infertility or repeated abortions if not attended or treated at proper time.
PCOD is one of such disorder which commonly affects second or third decade of life in females. It is important to know thoroughly about this condition as modern science has no root cause treatment to treat it. Also the treatment of modern science implicated leads to serious side effects and dependency of the medicines. PCOD is diagnosed in Ayurveda according to its presentation in so many ways depending upon its hetu, lakshana, dosha-dushya, samprapti.

https://doi.org/10.52482/ayurline.v1i02.59
PDF

I  declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form

Downloads

Download data is not yet available.